Jane Street’s Navidea Biopharmaceuticals Inc. NAVB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-19,474
| Closed | -$12K | – | 4366 |
|
|
2019
Q2 | $12K | Buy |
+19,474
| New | +$12K | ﹤0.01% | 3452 |
|
|
2019
Q1 | – | Sell |
-2,385
| Closed | -$5K | – | 4059 |
|
|
2018
Q4 | $5K | Buy |
2,385
+50
| +2% | +$105 | ﹤0.01% | 3143 |
|
|
2018
Q3 | $11K | Buy |
+2,335
| New | +$11K | ﹤0.01% | 3407 |
|
|
2018
Q2 | – | Sell |
-1,508
| Closed | -$11K | – | 4029 |
|
|
2018
Q1 | $11K | Sell |
1,508
-3,291
| -69% | -$24K | ﹤0.01% | 3027 |
|
|
2017
Q4 | $34K | Sell |
4,799
-4,983
| -51% | -$35.3K | ﹤0.01% | 2977 |
|
|
2017
Q3 | $81K | Buy |
9,782
+2,344
| +32% | +$19.4K | ﹤0.01% | 2754 |
|
|
2017
Q2 | $76K | Buy |
7,438
+4,807
| +183% | +$49.1K | ﹤0.01% | 2722 |
|
|
2017
Q1 | $30K | Buy |
2,631
+1,710
| +186% | +$19.5K | ﹤0.01% | 2670 |
|
|
2016
Q4 | $12K | Sell |
921
-2,188
| -70% | -$28.5K | ﹤0.01% | 2533 |
|
|
2016
Q3 | $57K | Sell |
3,109
-8,035
| -72% | -$147K | ﹤0.01% | 2647 |
|
|
2016
Q2 | $118K | Buy |
11,144
+3,757
| +51% | +$39.8K | ﹤0.01% | 2448 |
|
|
2016
Q1 | $140K | Sell |
7,387
-2,761
| -27% | -$52.3K | ﹤0.01% | 2370 |
|
|
2015
Q4 | $270K | Sell |
10,148
-20,522
| -67% | -$546K | ﹤0.01% | 2084 |
|
|
2015
Q3 | $1.4M | Buy |
+30,670
| New | +$1.4M | 0.01% | 863 |
|
|
2015
Q1 | – | Sell |
-1,195
| Closed | -$45K | – | 2639 |
|
|
2014
Q4 | $45K | Buy |
+1,195
| New | +$45K | ﹤0.01% | 1733 |
|
|
2014
Q3 | – | Sell |
-1,406
| Closed | -$42K | – | 2957 |
|
|
2014
Q2 | $42K | Buy |
+1,406
| New | +$42K | ﹤0.01% | 2160 |
|
|
2014
Q1 | – | Sell |
-1,101
| Closed | -$46K | – | 2946 |
|
|
2013
Q4 | $46K | Sell |
1,101
-7
| -0.6% | -$292 | ﹤0.01% | 1976 |
|
|
2013
Q3 | $59K | Sell |
1,108
-1,794
| -62% | -$95.5K | ﹤0.01% | 2301 |
|
|
2013
Q2 | $155K | Buy |
+2,902
| New | +$155K | ﹤0.01% | 2032 |
|